# High "on Treatment" Platelet Reactivity in the Intensive Care Unit

> **NCT02285751** · PHASE2 · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 200 (estimated)

## Conditions studied

- Critical Illness

## Interventions

- **DRUG:** acetylsalicylic acid
- **DRUG:** clopidogrel
- **DRUG:** prasugrel
- **DRUG:** ticagrelor

## Key facts

- **NCT ID:** NCT02285751
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-11
- **Primary completion:** 2020-07
- **Final completion:** 2020-08
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02285751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02285751, "High "on Treatment" Platelet Reactivity in the Intensive Care Unit". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02285751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*